The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 29, 2025

Filed:

Sep. 18, 2023
Applicant:

Aseko, Inc., Greenville, SC (US);

Inventors:

Robert C. Booth, Greer, SC (US);

Harry Hebblewhite, Atlanta, GA (US);

Assignee:

Glytec, LLC, Greenville, SC (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G16H 40/67 (2017.12); A61B 5/00 (2005.12); A61B 5/145 (2005.12); A61M 5/14 (2005.12); A61M 5/142 (2005.12); A61M 5/172 (2005.12); G16H 10/40 (2017.12); G16H 20/17 (2017.12); G16H 20/60 (2017.12); G16H 80/00 (2017.12);
U.S. Cl.
CPC ...
G16H 40/67 (2017.12); A61B 5/14532 (2012.12); A61B 5/4839 (2012.12); A61M 5/14 (2012.12); A61M 5/1723 (2012.12); G16H 10/40 (2017.12); G16H 20/17 (2017.12); G16H 20/60 (2017.12); G16H 80/00 (2017.12); A61B 5/4848 (2012.12); A61M 2005/14208 (2012.12); A61M 2005/14296 (2012.12); A61M 2005/1726 (2012.12); A61M 2205/18 (2012.12); A61M 2205/3327 (2012.12); A61M 2205/35 (2012.12); A61M 2205/3553 (2012.12); A61M 2205/3584 (2012.12); A61M 2205/3592 (2012.12); A61M 2205/50 (2012.12); A61M 2205/502 (2012.12); A61M 2205/507 (2012.12); A61M 2205/52 (2012.12); A61M 2205/581 (2012.12); A61M 2230/201 (2012.12);
Abstract

A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment for tube-fed patients from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The subcutaneous insulin treatment program for tube-fed patients determines recommended insulin doses based on the blood glucose times. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.


Find Patent Forward Citations

Loading…